Alder Matthias
Chief Executive Officer at GANX; EVP, Bus. Dev.&Lic, G.C. &Sec. at Sucampo Pharmaceuticals, Inc.; SVP & General Counsel at MICROMET, INC.
- Sold, on record
- $2.6M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Dec 21, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- GANXGain Therapeutics, Inc.Chief Executive Officer
- Sucampo Pharmaceuticals, Inc.EVP, Bus. Dev.&Lic, G.C. &Sec.
- MICROMET, INC.SVP & General Counsel
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Sucampo Pharmaceuticals, Inc.150,000 shares
- MICROMET, INC.20,000 shares
- GANX2,026 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale MICROMET, INC.UnusualJan 19, 2010 2010
Sold 10,000 shares at $7.16 ($72k)
Alder Matthias, Sr.VP and General Counsel
Sold 100% of holdings ($72k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale MICROMET, INC.UnusualJan 25, 2010 +6 days
Sold 10,000 shares at $8.25 ($83k)
Alder Matthias, SVP & General Counsel
Sold 100% of holdings ($83k position)0 shares leftFiling
- 3 Form 4 sale Sucampo Pharmaceuticals, Inc.UnusualNov 28, 2016 +2499 days
Sold 150,000 shares at $16.00 ($2.4M)
Alder Matthias, EVP, Bus. Dev.&Lic, G.C. &Sec.
Sold 97.8% of holdings ($2.5M position)3,449 shares leftFirst sale on recordFiling
- 4 Form 4 sale GANXUnusualDec 7, 2023 +2565 days
Sold 1,820 shares at $2.50 ($5k)
Alder Matthias, Chief Executive Officer
No 10b5-1 planSold 27.3% of holdings ($17k position)4,855 shares leftFirst sale on recordFiling
- 5 Form 4 sale GANXNo planDec 21, 2023 +14 days
Sold 206 shares at $2.46 ($507)
Alder Matthias, Chief Executive Officer
No 10b5-1 planSold 3.8% of holdings ($14k position)5,286 shares leftFiling
Every transaction
Loading transactions…
Sales and notices (5)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | Dec 22, 2023 | GANX | Chief Executive Officer | Form 4 sale | 206 | $507 | 3.8% | No plan | SEC |
| Dec 7, 2023 | Dec 14, 2023 | GANX | Chief Executive Officer | Form 4 sale | 1,820 | $5k | 27.3% | Unusual | SEC |
| Nov 28, 2016 | Nov 28, 2016 | Sucampo Pharmaceuticals, Inc. | EVP, Bus. Dev.&Lic, G.C. &Sec. | Form 4 sale | 150,000 | $2.4M | 97.8% | Unusual | SEC |
| Jan 25, 2010 | Jan 27, 2010 | MICROMET, INC. | SVP & General Counsel | Form 4 sale | 10,000 | $83k | 100.0% | Unusual | SEC |
| Jan 19, 2010 | Jan 21, 2010 | MICROMET, INC. | Sr.VP and General Counsel | Form 4 sale | 10,000 | $72k | 100.0% | Unusual | SEC |